EDEN PRAIRIE, Minn., June 29, 2017 (GLOBE NEWSWIRE) — CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that researchers in the Stanford University School of Medicine’s Department of Pediatrics have received FDA Investigational Device Exemption (IDE) approval to conduct a clinical study to evaluate the safety and effectiveness […]
Coronary/Structural Heart
Royal Philips Electronics N.V. (PHG) Slams Down $2.16 Billion for Spectranetics (SPNC)
6/28/2017 5:53:44 AM Philips To Acquire The Spectranetics Corporation To Accelerate Expansion In Image-Guided Therapy Devices To Treat Cardiac And Peripheral Vascular Disease AMSTERDAM, the Netherlands and COLORADO SPRINGS, Colo., June 28, 2017 (GLOBE NEWSWIRE) — Royal Philips(NYSE:PHG) (AEX:PHIA), a global leader in health technology, and The Spectranetics Corporation (NASDAQ:SPNC), a U.S.-based global […]
General Practitioners at Risk of Missing Cardiovascular Disease
NEWS PROVIDED BY CRICO Strategies 27 Jun, 2017, 10:33 ET BOSTON, June 27, 2017 /PRNewswire/ — When doctors miss a diagnosis of cardiovascular disease in an outpatient setting, the patient often has conventional risk factors for coronary artery disease, a groundbreaking study reveals. The research, published online today in The Joint Commission Journal on Quality […]
Teleflex (TFX) Announces 510(k) Clearance and Global Launch of Twin-Pass® Torque Dual Access Catheter
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance by the Food and Drug Administration and both U.S. and international commercial launch of the Twin-Pass Torque Dual Access Catheter. “The Twin-Pass Torque Catheter builds on Vascular Solutions’ […]
BioImage-2 Starts: Ultrasound Imaging for Cardiac Risk Prediction Looks at Disease Progression
NEW YORK, June 20, 2017 /PRNewswire/ — Mount Sinai Heart and BioImage-2 LLC, today announced start of the BioImage-2 study. The BioImage-2 study investigates the progression of vascular atherosclerotic plaque in patients who previously participated in the BioImage study. That landmark study recruited 7,687 volunteer participants from Humana members in Greater […]
Italian Boy Becomes Youngest Patient Bridged To Transplant With The SynCardia Total Artificial Heart
The smaller 50cc Total Artificial Heart helped rejuvenate the critically-ill 12-year-old’s vital organs until a matching donor heart became available two weeks later. TUCSON, Ariz.–(BUSINESS WIRE)–A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be bridged to a heart transplant with […]
TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon
PLEASANTON, Calif., June 21, 2017 /PRNewswire/ — TriReme Medical LLC (the “Company”), a subsidiary of QT Vascular Ltd, announced today its angiographic data from 24-month follow-up of patients with De Novo lesions treated with Chocolate Heart™ as a standalone therapy. The initial six-month results were announced on 5 January 2016. Chocolate Heart™ […]
FDA Green Lights ClearFlow’s FlowGlide Technology for Cardiac Surgery Patients
ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that the United States Food & Drug Administration (FDA) has granted 510[k] clearance for the company’s proprietary FlowGlide™ Active Clearance Technology® System. “The new design helps resist kinks, and allows positioning of the catheters into harder-to-reach […]
San Diego’s REVA Medical Completes $34.6 Million Funding Round
SAN DIEGO, June 19, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announces that it has closed the second tranche and, therefore, has completed the financing transaction announced in April 2017 and approved by the Company’s shareholders on June 1, 2017. Completion occurred on June 16, […]
Mitralign Announces Enrollment of First European Subject in Transcatheter Tricuspid Repair Study Enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair
TEWKSBURY, Mass. & MILAN–(BUSINESS WIRE)–Mitralign Inc., an innovative developer of transcatheter tricuspid and mitral valve repair solutions, announced today the commencement of its SCOUT II study in Europe, with the Trialign System for the treatment of patients suffering from tricuspid regurgitation. “We are pleased to be the first center in […]


